Evidence map›Paper›PMID 41493577›Full record

ReviewJournal of neural transmission (Vienna, Austria : 1996)2026

The lifespan continuum of brain disorders: investigating links between neurodevelopmental and neurodegenerative disease-chicken or egg?

Jeswinder Sian-Hulsmann, Laust Vind Knudsen, Abigail Jane Sheldrick-Michel, Peter Riederer, Tanja Maria Michel

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jeswinder Sian-Hulsmann *Department of Human Anatomy and Medical Physiology, University of Nairobi, P.O. Box 30197, Nairobi, 00100, Kenya.
Laust Vind Knudsen *Research Unit, Department of Psychiatry, Odense, University of Southern Denmark, University Hospital of Southern Denmark, Region of Southern Denmark, J.B. Winsløwsvej 20, Odense, 5000, Denmark.
Abigail Jane Sheldrick-MichelResearch Unit, Department of Psychiatry, Odense, University of Southern Denmark, University Hospital of Southern Denmark, Region of Southern Denmark, J.B. Winsløwsvej 20, Odense, 5000, Denmark.
Peter Riederer *Clinic and Policlinic for Psychiatry, Psychosomatics and Psychotherapy, University Hospital Wuerzburg, University of Wuerzburg, Wuerzburg, Germany. Peter.Riederer@uni-wuerzburg.de.ORCID 0000-0002-3453-6335
Tanja Maria Michel *Research Unit, Department of Psychiatry, Odense, University of Southern Denmark, University Hospital of Southern Denmark, Region of Southern Denmark, J.B. Winsløwsvej 20, Odense, 5000, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing evidence indicates that neurodevelopmental disorders, such as autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD), may be linked to a higher risk of developing neurodegenerative diseases, including Parkinson’s disease (PD) and Alzheimer’s disease (AD), later in life. Traditionally, these conditions have been viewed as fundamentally different in their causes, symptoms, and progression. Neurodevelopmental disorders appear early in life, while neurodegenerative diseases usually develop later, often in older age. However, recent research is increasingly highlighting shared molecular mechanisms and pathophysiological features across these disorder groups. Notably, shared processes such as oxidative stress, chronic neuroinflammation, and metabolic dysregulation have emerged as key contributors. Understanding these convergences may open the door to novel, targeted therapeutic strategies. This review critically examines the current evidence supporting potential links between neurodevelopmental conditions such as ASD and ADHD, and neurodegenerative diseases like AD and PD. While some pathological and molecular data suggest overlapping mechanisms, the overall evidence remains mixed and, in many aspects, inconclusive. Although associations between neurodevelopmental disorders and an increased risk of neurodegenerative diseases appear compelling in certain studies, the precise etiological pathways underlying these relationships remain poorly understood. Comorbidities such as depression, chronic stress, metabolic disturbances, and lifestyle-related factors are likely to act as mediators, potentially amplifying vulnerability to cognitive decline, dementia, or parkinsonian features over time. To address these uncertainties, additional epidemiological and clinical research is needed to expand and validate the current evidence base and to clarify the potential links between neurodevelopmental and neurodegenerative conditions.

Indexed as

Aldehydes and neurodevelopmentAlzheimer's diseaseAttention-deficit/hyperactivity disorder (ADHD)Autism spectrum disorder (ASD)DementiaInflammationMitochondriaNeurodegenerationNeuroinflammation ironOxidative stressParkinson’s diseaseRespiratory chain activity

Identifiers

PMID41493577

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.